These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16709730)

  • 1. Expression of the human copper influx transporter 1 in normal and malignant human tissues.
    Holzer AK; Varki NM; Le QT; Gibson MA; Naredi P; Howell SB
    J Histochem Cytochem; 2006 Sep; 54(9):1041-9. PubMed ID: 16709730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
    Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
    Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.
    Holzer AK; Katano K; Klomp LW; Howell SB
    Clin Cancer Res; 2004 Oct; 10(19):6744-9. PubMed ID: 15475465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The internalization and degradation of human copper transporter 1 following cisplatin exposure.
    Holzer AK; Howell SB
    Cancer Res; 2006 Nov; 66(22):10944-52. PubMed ID: 17108132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, localisation and hormone regulation of the human copper transporter hCTR1 in placenta and choriocarcinoma Jeg-3 cells.
    Hardman B; Manuelpillai U; Wallace EM; Monty JF; Kramer DR; Kuo YM; Mercer JF; Ackland ML
    Placenta; 2006; 27(9-10):968-77. PubMed ID: 16356544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haymaker gene expression in malignant and normal gynecologic tissues.
    Borowsky ME; Das B; Axiotis CA; Malka ES; Abulafia O; Norin AJ
    J Histochem Cytochem; 2006 Jul; 54(7):753-61. PubMed ID: 16495475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of Glut3 in human tumors and normal tissues.
    Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
    Anticancer Res; 1997; 17(4A):2747-50. PubMed ID: 9252709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
    Du X; Wang X; Li H; Sun H
    Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1).
    Klomp AE; Tops BB; Van Denberg IE; Berger R; Klomp LW
    Biochem J; 2002 Jun; 364(Pt 2):497-505. PubMed ID: 12023893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
    Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
    J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity.
    Giatromanolaki A; Sivridis E; Maltezos E; Koukourakis MI
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):14-21. PubMed ID: 12577238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human copper transporter hCTR1 mediates basolateral uptake of copper into enterocytes: implications for copper homeostasis.
    Zimnicka AM; Maryon EB; Kaplan JH
    J Biol Chem; 2007 Sep; 282(36):26471-80. PubMed ID: 17627945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PDE11A in normal and malignant human tissues.
    D'Andrea MR; Qiu Y; Haynes-Johnson D; Bhattacharjee S; Kraft P; Lundeen S
    J Histochem Cytochem; 2005 Jul; 53(7):895-903. PubMed ID: 15995148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular distribution of human tissue kallikreins: immunohistochemical localization.
    Petraki CD; Papanastasiou PA; Karavana VN; Diamandis EP
    Biol Chem; 2006 Jun; 387(6):653-63. PubMed ID: 16800726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
    Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
    Li W; Li L; Liu Z; Liu C; Liu Z; Strååt K; Björkholm M; Jia J; Xu D
    Cancer Lett; 2008 Feb; 260(1-2):28-36. PubMed ID: 18037230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody.
    Perk J; Gil-Bazo I; Chin Y; de Candia P; Chen JJ; Zhao Y; Chao S; Cheong W; Ke Y; Al-Ahmadie H; Gerald WL; Brogi E; Benezra R
    Cancer Res; 2006 Nov; 66(22):10870-7. PubMed ID: 17108123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance].
    An J; Guo RF; Zhang L; Geng PL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
    Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
    Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.